24 August 2020 3 Min Read
Blackstone buys Takeda’s medication unit in Japan for $2.3bn
Blackstone is flush with cash as investors continue to bet big on the firm as it shifts investments to businesses likely to benefit from Covid-related consumer behaviour
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In